Apex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement device
Advertisement
New Delhi: In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to compensate a consumer with Rs 35 lakh for medical complications arising from the company's defective hip replacement device. The commission, comprised of presiding member Ram Surat Maurya along with members Subhash Chandra and Inder Jit Singh, was hearing a complaint filed by Purushotham Lohia, who had sought Rs 5 crore in compensation after suffering ongoing health issues following the use of the DePuy's Acetabular System Resurfacing (ASR XL) hip implant.
According to Lohia, he underwent total hip replacement surgery with the ASR XL device. It said that though the opposite parties reimbursed Rs 25 lakh for Lohia's revision surgery, in May 2017, no compensation was paid for his losses.
"Even today the complainant walks with a noticeable limp and pain even after revision surgery and is not in a position to carry out his professional work. The family of the complainant also suffered trauma due to the negligence of the opposite party," the plea said.
According to PTI, in its order dated September 3, the NCDRC said that an expert committee, constituted by the Centre to examine the various issues about faulty ASR hip implants, and some judgements of foreign courts concluded that the implant was defective because of its design and that the company was strictly liable for the defective design.
Noting the medical evidence, it said that the "inherently defective design" of the devices resulted in various complications for the patients, such as increased levels of chromium and cobalt, necessitating premature revision surgeries.
"Hence, we are of the view that all such patients or complainants in India, who have used the ASR XL implant and have undergone revision surgeries prematurely, are entitled to a certain minimum or basic level of compensation, irrespective of the nature and extent of complications which such implants caused.
"We consider that Rs 35 lakh is a just and fair amount to be fixed as basic or minimum amount of compensation to each of the patient or complainant, who have used the implant in question and who had already undergone revision surgery at any time till the date of this order," the commission said.
It directed Johnson & Johnson Limited to pay Rs 35 lakh, inclusive of Rs 25 lakh already reimbursed as medical expenses, to the complainant within two months.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.